Staphylococcus Aureus Testing Market Size & Trend 2033

Q: What is the CAGR from 2023 to 2033?

The CAGR of this market is 5.3% through 2033 Read Report

Q: What is North America's expected share in 2023?

North America is likely to generate 48.7% revenue in 2023 Read Report

Staphylococcus Aureus Testing Market Outlook

The Staphylococcus aureus testing market is likely to cross the estimated market value of US$ 6.9 billion by 2033 while it thrives in the global market at a lower CAGR of 5.3% (2023 to 2033). The market holds a revenue of US$ 4.1 billion in 2023.

The market survey states that the rising number of infections is caused by Staphylococcus aureus. These infections include skin, bacteremia, soft tissue, and infective endocarditis. Furthermore, advanced technology is integrating with diagnostic procedures for staphylococcus aureus as it grows rapidly. The applications of staphylococcus aureus testing in cases of abscesses, furuncles, and cellulitis are rising with the growing awareness around skin care.

The Staphylococcus aureus market outlook shows that the market has been growing steadily since the last forecast cycle. This growth is attributed to the high risks of infected blood fluids and contaminated hands. The increasing sales of staphylococcus aureus testing systems are attributed to the growing geriatric population and skin health awareness. Staphylococcus aureus has long been recognized as an important bacteria that cause different human diseases.

Abscess infections include pocket infections formed around the site of injury that are pus-filled and pocket infections formed around the site of injury that is pus-filled in nature. Cellulitis involves an infection of the underlying layers of the skin. It happens due to some scrape or cut through the skin. The long types of infections are followed by their diagnosis of them. Hence the demand for staphylococcus aureus testing.

Attributes	Details
Market CAGR (2023 to 2033)	5.3%
Market Valuation (2023)	US$ 4.1 billion
Market Valuation (2033)	US$ 6.9 billion

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What are the Major Drivers and Restraints of the Global Market?

The growing incidence of staph infections is the major factor driving the growth of the global market. An inappropriate sanitary environment is the major cause of the spread of Staph infections. Staphylococcus aureus screening is the mandatory screening test before taking insulin, and growing awareness of bacterial infection across the globe is expected to push the sales of staphylococcus aureus testing systems.

Advanced rapid diagnostic tests availability also boosts the market's growth over the forecast period. However, inadequate reimbursement in developing the region and limited access to regular healthcare may be the restraints for the global market.

Growth Prospects:

Test-based Developments

Both rapid and reliable tests gained traction in the last forecast cycle with the new advanced technology like big data integrating with the test documentation, providing info like patient's history and nature of infection for better treatment.
New RAPIDEC staph kits are used to detect the staphylococcus aureus bacteria that detect directly through the vital blood culture system.
Some Staphylococcus aureus strains can produce staphylococcal enterotoxins (SEs), the causative agents of staphylococcal food poisoning. NCBI has been introduced to detect these agents through a specific

Market-based Developments

Big companies like Hygiene are launching rapid BAX System PCR Assays for detecting staphylococcus aureus to help the end user healthcare systems.
As companies focus more on accuracy and less on the packaging and marketing of these testing kits. Bio-Rad labs have introduced its TC-139 testing kits that have to shorten the result time.

Sales Analysis of Staphylococcus Aureus Testing Market from 2018 to 2022 Vs Market Outlook for 2023 to 2033

The global market is projected to rise at an impressive CAGR of 5.3% between 2023 and 2033, compared to a 6.7% CAGR registered from 2018 to 2022. The market secured a valuation of US$ 2.8 billion in 2018 and US$ 3.9 billion in 2022.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Regional Analysis

What is the North America Growth Outlook for the Market?

Emerging trends in the market state that the North American market holds a significant market share, with 48.7% of the global market share. The growth factors that work for the development of the market are increasing contaminated infections, pollution and proliferated bacteria counts in food products that lead to higher sensitivity levels in Americans.

Oxford Academic states that the high burden of staphylococcus aureus among Native American individuals on the White Mountain Apache tribal lands is rising. It increases demand for staphylococcus aureus testing in the region.

How is the European Market Shaping?

With a global market share of 33.4%, the European market is growing at an impressive CAGR as the covid-19 has slowed down bacteria contamination.

The new advanced technology, with its highly accurate results, is taking the lead in the market in the region. However, the logistics ban and lockdown have slowed down the market’s pace as there was limited human density in public spaces. Furthermore, the market recovers as the awareness of bacteria-based infections and diseases rises with the changing climate.

How are Startups Structuring the Global Market?

Staphylococcus aureus testing startup survey at future marketing insights explains that just like other healthcare/medical/diagnostics market spaces, this market is full of startup ideas that show interest in the rapidly changing diagnosis industry.

The new companies are investing more in the core workings of the staphylococcus aureus testing systems that reduce the testing time and increase the accuracy of the results. As the climate changes and new bacteria-based diseases expand, the different variants of Abscess and Cellulitis infections.

How Key Players are Contributing to the Global Market?

Key players now add more value to the accuracy of tests and logistics of these Staphylococcus aureus testing systems generally found in diagnostic centers. The new and advanced technology used detects all types of infections. The new startup is shaping the competitive landscape into more edgy and friendly.

Recent mergers and product launches

Abbott Laboratories has introduced its Abbott MS-2 system for staphylococcus aureus testing, which is methicillin-resistant. The agreement between Abbott MS-2 and standard disk diffusion methods procedure has been 94% greater than the antibiotics tested.

Thermofisher Scientific has introduced the Staphylococcal Enterotoxin Reversed Passive Latex Agglutination Kit (SET-RPLA) that detects enterotoxins A, B, C and D in food samples or culture filtrates. Reversed passive latex agglutination (RPLA) enables soluble antigens, such as bacterial toxins, to be detected in an agglutination assay.

Key players

Abbott Laboratories Inc
Siemens Healthcare GmbH
Bio Rad Laboratories Inc
Thermo Fisher Scientific Inc
Roche Diagnostics (H. Hoffman-La Roche Ltd.)
STD Rapid Test Kits

Scope of Report

Attributes	Details
Forecast Period	2023 to 2033
Historical Data Available for	2018 to 2022
Market Analysis	US$ billion for Value
Key Countries Covered	United States, United Kingdom, Japan, India, China, Australia, Germany
Key Segments Covered	Product, Application, End User, Region
Key Companies Profiled	Abbott Laboratories Inc; Siemens Healthcare GmbH; Bio Rad Laboratories Inc; Thermo Fisher Scientific Inc; Roche Diagnostics (H. Hoffman-La Roche Ltd.); STD Rapid Test Kits
Report Coverage	Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing	Available upon Request

Staphylococcus Aureus Testing Market by Category

By Test Type:

Coagulase Test
Ancillary Tests
Agar-Based Tests
Nucleic Acid Amplification Tests

By Application:

Pharmaceutical
Clinical
Food Testing
Other

By End User:

Hospitals
Diagnostic Clinics
Food Testing laboratories
Others

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East and Africa

Frequently Asked Questions

What is the CAGR from 2023 to 2033?

The CAGR of this market is 5.3% through 2033

Which Region holds high Lucrativeness?

North America is projected to emerge as a lucrative market.

What Limits the Growth Potential of the Market?

Limited access to regular healthcare limits the market growth.

What is North America's expected share in 2023?

North America is likely to generate 48.7% revenue in 2023

What drives sales in this market?

Growing awareness of bacterial infection is expected to drive sales.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Investment Feasibility Matrix

3.5. PESTLE and Porter’s Analysis

3.6. Regulatory Landscape

3.6.1. By Key Regions

3.6.2. By Key Countries

3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Type

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ Million) Analysis By Test Type, 2018 to 2022

5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Type, 2023 to 2033

5.3.1. Coagulase Test

5.3.2. Ancillary Tests

5.3.3. Agar-Based Tests

5.3.4. Nucleic Acid Amplification Tests

5.4. Y-o-Y Growth Trend Analysis By Test Type, 2018 to 2022

5.5. Absolute $ Opportunity Analysis By Test Type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

6.1. Introduction / Key Findings

6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022

6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033

6.3.1. Pharmaceutical

6.3.2. Clinical

6.3.3. Food Testing

6.3.4. Other

6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022

6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

7.1. Introduction / Key Findings

7.2. Historical Market Size Value (US$ Million) Analysis by End User, 2018 to 2022

7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast by End User, 2023 to 2033

7.3.1. Hospitals

7.3.2. Diagnostic Clinics

7.3.3. Food Testing laboratories

7.3.4. Others

7.4. Y-o-Y Growth Trend Analysis by End User, 2018 to 2022

7.5. Absolute $ Opportunity Analysis by End User, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

8.1. Introduction

8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

8.3.1. North America

8.3.2. Latin America

8.3.3. Western Europe

8.3.4. Eastern Europe

8.3.5. South Asia and Pacific

8.3.6. East Asia

8.3.7. Middle East and Africa

8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

9.2.1. By Country

9.2.1.1. The USA

9.2.1.2. Canada

9.2.2. By Test Type

9.2.3. By Application

9.2.4. By End User

9.3. Market Attractiveness Analysis

9.3.1. By Country

9.3.2. By Test Type

9.3.3. By Application

9.3.4. By End User

9.4. Key Takeaways

10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

10.2.1. By Country

10.2.1.1. Brazil

10.2.1.2. Mexico

10.2.1.3. Rest of Latin America

10.2.2. By Test Type

10.2.3. By Application

10.2.4. By End User

10.3. Market Attractiveness Analysis

10.3.1. By Country

10.3.2. By Test Type

10.3.3. By Application

10.3.4. By End User

10.4. Key Takeaways

11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

11.2.1. By Country

11.2.1.1. Germany

11.2.1.2. United Kingdom

11.2.1.3. France

11.2.1.4. Spain

11.2.1.5. Italy

11.2.1.6. Rest of Western Europe

11.2.2. By Test Type

11.2.3. By Application

11.2.4. By End User

11.3. Market Attractiveness Analysis

11.3.1. By Country

11.3.2. By Test Type

11.3.3. By Application

11.3.4. By End User

11.4. Key Takeaways

12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

12.2.1. By Country

12.2.1.1. Poland

12.2.1.2. Russia

12.2.1.3. Czech Republic

12.2.1.4. Romania

12.2.1.5. Rest of Eastern Europe

12.2.2. By Test Type

12.2.3. By Application

12.2.4. By End User

12.3. Market Attractiveness Analysis

12.3.1. By Country

12.3.2. By Test Type

12.3.3. By Application

12.3.4. By End User

12.4. Key Takeaways

13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

13.2.1. By Country

13.2.1.1. India

13.2.1.2. Bangladesh

13.2.1.3. Australia

13.2.1.4. New Zealand

13.2.1.5. Rest of South Asia and Pacific

13.2.2. By Test Type

13.2.3. By Application

13.2.4. By End User

13.3. Market Attractiveness Analysis

13.3.1. By Country

13.3.2. By Test Type

13.3.3. By Application

13.3.4. By End User

13.4. Key Takeaways

14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

14.2.1. By Country

14.2.1.1. China

14.2.1.2. Japan

14.2.1.3. South Korea

14.2.2. By Test Type

14.2.3. By Application

14.2.4. By End User

14.3. Market Attractiveness Analysis

14.3.1. By Country

14.3.2. By Test Type

14.3.3. By Application

14.3.4. By End User

14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

15.2.1. By Country

15.2.1.1. GCC Countries

15.2.1.2. South Africa

15.2.1.3. Israel

15.2.1.4. Rest of MEA

15.2.2. By Test Type

15.2.3. By Application

15.2.4. By End User

15.3. Market Attractiveness Analysis

15.3.1. By Country

15.3.2. By Test Type

15.3.3. By Application

15.3.4. By End User

15.4. Key Takeaways

16. Key Countries Market Analysis

16.1. USA

16.1.1. Pricing Analysis

16.1.2. Market Share Analysis, 2022

16.1.2.1. By Test Type

16.1.2.2. By Application

16.1.2.3. By End User

16.2. Canada

16.2.1. Pricing Analysis

16.2.2. Market Share Analysis, 2022

16.2.2.1. By Test Type

16.2.2.2. By Application

16.2.2.3. By End User

16.3. Brazil

16.3.1. Pricing Analysis

16.3.2. Market Share Analysis, 2022

16.3.2.1. By Test Type

16.3.2.2. By Application

16.3.2.3. By End User

16.4. Mexico

16.4.1. Pricing Analysis

16.4.2. Market Share Analysis, 2022

16.4.2.1. By Test Type

16.4.2.2. By Application

16.4.2.3. By End User

16.5. Germany

16.5.1. Pricing Analysis

16.5.2. Market Share Analysis, 2022

16.5.2.1. By Test Type

16.5.2.2. By Application

16.5.2.3. By End User

16.6. United Kingdom

16.6.1. Pricing Analysis

16.6.2. Market Share Analysis, 2022

16.6.2.1. By Test Type

16.6.2.2. By Application

16.6.2.3. By End User

16.7. France

16.7.1. Pricing Analysis

16.7.2. Market Share Analysis, 2022

16.7.2.1. By Test Type

16.7.2.2. By Application

16.7.2.3. By End User

16.8. Spain

16.8.1. Pricing Analysis

16.8.2. Market Share Analysis, 2022

16.8.2.1. By Test Type

16.8.2.2. By Application

16.8.2.3. By End User

16.9. Italy

16.9.1. Pricing Analysis

16.9.2. Market Share Analysis, 2022

16.9.2.1. By Test Type

16.9.2.2. By Application

16.9.2.3. By End User

16.10. Poland

16.10.1. Pricing Analysis

16.10.2. Market Share Analysis, 2022

16.10.2.1. By Test Type

16.10.2.2. By Application

16.10.2.3. By End User

16.11. Russia

16.11.1. Pricing Analysis

16.11.2. Market Share Analysis, 2022

16.11.2.1. By Test Type

16.11.2.2. By Application

16.11.2.3. By End User

16.12. Czech Republic

16.12.1. Pricing Analysis

16.12.2. Market Share Analysis, 2022

16.12.2.1. By Test Type

16.12.2.2. By Application

16.12.2.3. By End User

16.13. Romania

16.13.1. Pricing Analysis

16.13.2. Market Share Analysis, 2022

16.13.2.1. By Test Type

16.13.2.2. By Application

16.13.2.3. By End User

16.14. India

16.14.1. Pricing Analysis

16.14.2. Market Share Analysis, 2022

16.14.2.1. By Test Type

16.14.2.2. By Application

16.14.2.3. By End User

16.15. Bangladesh

16.15.1. Pricing Analysis

16.15.2. Market Share Analysis, 2022

16.15.2.1. By Test Type

16.15.2.2. By Application

16.15.2.3. By End User

16.16. Australia

16.16.1. Pricing Analysis

16.16.2. Market Share Analysis, 2022

16.16.2.1. By Test Type

16.16.2.2. By Application

16.16.2.3. By End User

16.17. New Zealand

16.17.1. Pricing Analysis

16.17.2. Market Share Analysis, 2022

16.17.2.1. By Test Type

16.17.2.2. By Application

16.17.2.3. By End User

16.18. China

16.18.1. Pricing Analysis

16.18.2. Market Share Analysis, 2022

16.18.2.1. By Test Type

16.18.2.2. By Application

16.18.2.3. By End User

16.19. Japan

16.19.1. Pricing Analysis

16.19.2. Market Share Analysis, 2022

16.19.2.1. By Test Type

16.19.2.2. By Application

16.19.2.3. By End User

16.20. South Korea

16.20.1. Pricing Analysis

16.20.2. Market Share Analysis, 2022

16.20.2.1. By Test Type

16.20.2.2. By Application

16.20.2.3. By End User

16.21. GCC Countries

16.21.1. Pricing Analysis

16.21.2. Market Share Analysis, 2022

16.21.2.1. By Test Type

16.21.2.2. By Application

16.21.2.3. By End User

16.22. South Africa

16.22.1. Pricing Analysis

16.22.2. Market Share Analysis, 2022

16.22.2.1. By Test Type

16.22.2.2. By Application

16.22.2.3. By End User

16.23. Israel

16.23.1. Pricing Analysis

16.23.2. Market Share Analysis, 2022

16.23.2.1. By Test Type

16.23.2.2. By Application

16.23.2.3. By End User

17. Market Structure Analysis

17.1. Competition Dashboard

17.2. Competition Benchmarking

17.3. Market Share Analysis of Top Players

17.3.1. By Regional

17.3.2. By Test Type

17.3.3. By Application

17.3.4. By End User

18. Competition Analysis

18.1. Competition Deep Dive

18.1.1. Abbott Laboratories Inc

18.1.1.1. Overview

18.1.1.2. Product Portfolio

18.1.1.3. Profitability by Market Segments

18.1.1.4. Sales Footprint

18.1.1.5. Strategy Overview

18.1.1.5.1. Marketing Strategy

18.1.2. Siemens Healthcare GmbH

18.1.2.1. Overview

18.1.2.2. Product Portfolio

18.1.2.3. Profitability by Market Segments

18.1.2.4. Sales Footprint

18.1.2.5. Strategy Overview

18.1.2.5.1. Marketing Strategy

18.1.3. Bio Rad Laboratories Inc

18.1.3.1. Overview

18.1.3.2. Product Portfolio

18.1.3.3. Profitability by Market Segments

18.1.3.4. Sales Footprint

18.1.3.5. Strategy Overview

18.1.3.5.1. Marketing Strategy

18.1.4. Thermo Fisher Scientific Inc

18.1.4.1. Overview

18.1.4.2. Product Portfolio

18.1.4.3. Profitability by Market Segments

18.1.4.4. Sales Footprint

18.1.4.5. Strategy Overview

18.1.4.5.1. Marketing Strategy

18.1.5. Roche Diagnostics (H. Hoffman-La Roche Ltd.)

18.1.5.1. Overview

18.1.5.2. Product Portfolio

18.1.5.3. Profitability by Market Segments

18.1.5.4. Sales Footprint

18.1.5.5. Strategy Overview

18.1.5.5.1. Marketing Strategy

18.1.6. STD Rapid Test Kits

18.1.6.1. Overview

18.1.6.2. Product Portfolio

18.1.6.3. Profitability by Market Segments

18.1.6.4. Sales Footprint

18.1.6.5. Strategy Overview

18.1.6.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Staphylococcus Aureus Testing Market

Detailed Analysis of Staphylococcus Aureus Testing Market By Coagulase Test, Ancillary Tests, Agar-Based Tests, and Nucleic Acid Amplification Tests.